In ischemic LV dysfunction, adding PCI to medical therapy did not reduce a composite of death or aborted sudden death
- PMID: 37931266
- DOI: 10.7326/J23-0088
In ischemic LV dysfunction, adding PCI to medical therapy did not reduce a composite of death or aborted sudden death
Abstract
Perera D, Morgan HP, Ryan M, et al; REVIVED-BCIS2 Investigators. Arrhythmia and death following percutaneous revascularization in ischemic left ventricular dysfunction: prespecified analyses from the REVIVED-BCIS2 trial. Circulation. 2023;148:862-871. 37555345.
Conflict of interest statement
Comment on
-
Arrhythmia and Death Following Percutaneous Revascularization in Ischemic Left Ventricular Dysfunction: Prespecified Analyses From the REVIVED-BCIS2 Trial.Circulation. 2023 Sep 12;148(11):862-871. doi: 10.1161/CIRCULATIONAHA.123.065300. Epub 2023 Aug 9. Circulation. 2023. PMID: 37555345 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous